Saskia Middeldorp

Research activity per year

If you made any changes in Pure these will be visible here soon.

Etiology and treatment of venous thromboembolism

Vascular Medicine, research line of Thrombosis and Haemostasis

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
AUTHOR GROUP, 2016, In: New England Journal of Medicine. 375, 12, p. 1131-1141
Research output: Contribution to journal › Article › Academic › peer-review

590 Citations (Scopus)
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
AUTHOR GROUP, 2013, In: New England Journal of Medicine. 369, 15, p. 1406-1415
Research output: Contribution to journal › Article › Academic › peer-review

1412 Citations (Scopus)
A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function
Cunha, M. L. R., Bakhtiari, K., Peter, J., Marquart, J. A., Meijers, J. C. M. & Middeldorp, S., 2015, In: Blood. 125, 11, p. 1822-1825
Research output: Contribution to journal › Article › Academic › peer-review

47 Citations (Scopus)
Antithrombotic therapy for pregnancy loss
de Jong, P. G., Goddijn, M. & Middeldorp, S., 2013, In: Human Reproduction Update. 19, 6, p. 656-673
Research output: Contribution to journal › Review article › Academic › peer-review

38 Citations (Scopus)
Mechanistic View of Risk Factors for Venous Thromboembolism
Reitsma, P. H., Versteeg, H. H. & Middeldorp, S., 2012, In: Arteriosclerosis, thrombosis, and vascular biology. 32, 3, p. 563-568
Research output: Contribution to journal › Article › Academic › peer-review

154 Citations (Scopus)

Personal profile